In this study, researchers compared the flax consumption of 2,999
women diagnosed with breast cancer with that of 3,370 healthy women.
Not exact matches
Black women who are diagnosed with breast cancer...
Women for whom genetic testing is recommended are: women who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast ca
Women for whom genetic testing is recommended are:
women who are diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral breast cancer, have ovarian cancer, have triple negative breast cancer, or have 2 or more family members with breast ca
women who are
diagnosed with breast cancer under the age of 50, are of Ashkenazi ancestry, have bilateral
breast cancer, have ovarian
cancer, have triple negative
breast cancer, or have 2 or more family members
with breast cancer.
Survival rates for
women diagnosed with inflammatory
breast cancer are grim.
There are nearly 220,000
women diagnosed with breast cancer every year in the U.S. and approximately 40,000 die of it annually.
About 41,000
women and 300 men are
diagnosed with breast cancer every year, and in five per cent of cases the disease is caused by a hereditary mutation in the BRCA1 and BRCA2
breast cancer genes.
«Intrabeam radiotherapy is another exciting development and could dramatically improve the quality of life of some
women diagnosed with breast cancer, but there is not yet evidence of its long term benefits.
Nearly a fifth (17 %) of
women who have been
diagnosed with breast cancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000 women every year in the UK, according to calculations based on new YouGov figures released today from Breast Cancer
breast cancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000 women every year in the UK, according to calculations based on new YouGov figures released today from Breast Cancer
cancer after spotting a potential symptom wait over a month before seeing their GP, equating to an estimated 6,000
women every year in the UK, according to calculations based on new YouGov figures released today from
Breast Cancer
Breast CancerCancer Care.
James said that while there is a 99 percent survival rate if
breast cancer is detected early, black
women are 42 percent more likely to die from
breast cancer than their white counterparts and Hispanic
women have significantly higher rates of being
diagnosed with advanced
breast cancer than either white or black
women.
«Our helpline regularly hears from
women who are concerned about the risk of their
breast cancer returning after treatment, so we know that this research will be of great interest to
women, and men,
diagnosed with breast cancer.
Women aren't the only ones to get
breast cancer — men are
diagnosed with it, too.
Each year in New York, nearly 15,000
women are
diagnosed with breast cancer and about 2,700
women die from the disease.
Swanick and Smith used Medicare claims to prospectively identify
women 67 or older and
diagnosed with non-metastatic
breast cancer in 2009.
That means that roughly 36 of the 190
women who received annual mammography for 10 years and were
diagnosed with breast cancer would receive unnecessary surgery, chemotherapy or radiotherapy.
The researchers estimated that among 10,000
women in their 40s who undergo annual mammography for 10 years, about 190 will be
diagnosed with breast cancer.
To find out more, UK - based researchers from the Universities of Leicester and Greenwich reviewed 24 publications reporting
breast cancer screening practices in
women with mental illness (around 700,000), and five studies investigating screening for those in distress but who had not been
diagnosed with a mental illness (nearly 21,500).
In Switzerland alone, more than 5,700
women are
diagnosed with breast cancer each year, and almost 1,400 of those affected die of the disease.
In the United States, it is estimated that approximately 230,000
women will be
diagnosed with breast cancer in 2015.
Neoadjuvant chemotherapy, given for five to six months before surgery, is the standard treatment for some
women with newly
diagnosed invasive, but operable,
breast cancer.
Glass and his colleagues reviewed the medical histories of 7,386
women (in the database of Kaiser Permanente Northwest)
diagnosed with invasive
breast cancer between 1980 and 2006.
Identified via mammography and other screening technologies, DCIS is currently
diagnosed annually in about 60,000
women in the U.S., and is generally treated similarly to other more advanced
breast cancers with surgery and radiation therapy.
Using data from a previously published, multi-center study funded by the National
Cancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to women recently diagnosed with breast c
Cancer Institute, researchers aimed to identify the possible benefits of assigning patient navigators to
women recently
diagnosed with breast cancercancer.
Patient navigation, or the linking of a newly
diagnosed cancer patient
with a professional trained in assisting patients though the complex journey of
cancer diagnosis and treatment, may lead to better
breast cancer care in high risk and minority
women.
Among
women diagnosed with early - stage
breast cancer in California, the percentage undergoing a double mastectomy increased substantially between 1998 and 2011, although this procedure was not associated
with a lower risk of death than
breast - conserving surgery plus radiation, according to a study in the September 3 issue of JAMA.
A total of 848 physicians reported on 1,631
women they knew who had been
diagnosed with breast cancer, 771 of whom were patients, 381 family members and 474 other social network members.
The analysis also found that Asian / Pacific Islander
women were more likely to be
diagnosed with another subtype of
breast cancer: so - called human epidermal growth factor receptor 2 (HER2)- overexpressing
breast cancer.
During a median follow - up of 5 years, 426
women were
diagnosed with breast cancer, 109
with ovarian
cancer, and 245
with contralateral
breast cancer (
cancer in the
breast opposite to one previously
diagnosed with cancer).
Dr. Narod, who is also a Tier 1 Canada Research Chair in
Breast Cancer, recommends that doctors should consider adopting a standard model of care for all women diagnosed with advanced - stage ovarian c
Cancer, recommends that doctors should consider adopting a standard model of care for all
women diagnosed with advanced - stage ovarian
cancercancer:
One in eight
women in the United States has a chance of being
diagnosed with breast cancer and an estimated 250,000 new cases of invasive
breast cancer are expected to be
diagnosed in 2017.
When Lisbeth Ceriani, a 43 - year - old Massachusetts
woman, was
diagnosed with breast cancer last year, her doctors recommended that she undergo genetic testing to see if she carried mutations in the BRCA1 and BRCA2 genes that increase risk of
breast and ovarian
cancers.
Researchers surveyed 2,362
women newly
diagnosed with early stage
breast cancer.
«In the future, we'd like to be able to profile individual
cancer genomes so that we can identify the treatment most likely to be successful for a
woman or man
diagnosed with breast cancer,» says Dr Nik - Zainal of the Sanger Institute.
The challenges of
diagnosing breast cancer in
women with dense
breasts has drawn national attention in recent years.
Seventy - five percent of
women diagnosed with breast cancer have no family history or other factors that place them at high risk for the disease.
Their analysis revealed that
women who underwent childbirth and who breastfed were
diagnosed with breast cancer at a later age, regardless of the patients» family history of
cancer.
A new study by UCLA scientists has found that
women diagnosed with breast cancer and treated
with a one - week regimen of partial
breast radiation after the surgical removal of the tumor, or lumpectomy, saw no increase in
cancer recurrence or difference in cosmetic outcomes compared to
women who received radiation of the entire
breast for a period of up to six weeks after surgery.
For the study, researchers used a Medicare - linked database to identify
women older than 65 who were
diagnosed in 2000 - 09
with stage I - III
breast cancer and received
cancer treatments that previously had been linked to heart problems.
A team of researchers based in Canada wanted to find out whether the stage at which
breast cancer is
diagnosed — and post-diagnosis survival — differed between
women with and without cosmetic
breast implants.
The findings at the Fred Hutch - led
Women's Health Initiative resulted in a change in menopause treatment that means 20,000 fewer women worldwide are diagnosed with breast cancer every
Women's Health Initiative resulted in a change in menopause treatment that means 20,000 fewer
women worldwide are diagnosed with breast cancer every
women worldwide are
diagnosed with breast cancer every year.
Comprehensive Study Includes All Danish
Women Diagnosed with Breast Cancer from 2000 to 2003 who were Indicated for Prosigna and Treated
with Endocrine Therapy
«More
women are now being
diagnosed with breast cancer than ever before, and these crucial findings could ultimately help us more accurately predict who is most at risk and develop new targeted treatments.
The study involved about 2,500
women from Europe, North America and Australia who have inherited mutations in BRCA1 or BRCA2, the
breast cancer susceptibility genes, and who had been
diagnosed with breast cancer.
But as fewer and fewer
women were
diagnosed with large
breast tumors, pre-op chemo began to be used in patients
with smaller
cancers, too, in the hope that it would extend survival.
Join Lillie's
Breast Cancer Angels» Club to help the Johns Hopkins Breast Cancer Survivor Volunteers provide support to women newly diagnosed with breast c
Breast Cancer Angels» Club to help the Johns Hopkins Breast Cancer Survivor Volunteers provide support to women newly diagnosed with breast c
Cancer Angels» Club to help the Johns Hopkins
Breast Cancer Survivor Volunteers provide support to women newly diagnosed with breast c
Breast Cancer Survivor Volunteers provide support to women newly diagnosed with breast c
Cancer Survivor Volunteers provide support to
women newly
diagnosed with breast c
breast cancercancer.
Young Survival Coalition (YSC) is the premier global organization dedicated to the critical issues unique to young
women who are
diagnosed with breast cancer.
Our mission is to offer a community of support to
women, of all Jewish backgrounds,
diagnosed with breast cancer or at increased genetic risk, by fostering culturally - relevant individualized connections
with networks of peers, health professionals, and related resources.
In fact, the U.S. Centers for Disease Control and Prevention (CDC) reported that an estimated 215,990 U.S.
women were
diagnosed with new cases of invasive
breast cancer and tens of thousands of
women died of the disease last year alone.
In Australia, approximately one in eight
women will be
diagnosed with breast cancer during their lifetime.
From an initial SEER / Medicare database cohort of 51,063
women with invasive
breast cancer diagnosed between 2002 and 2007, researchers drew a final study cohort of 31,274
women.
The researchers found that non-Hispanic white
women were more likely to have smaller tumors, and more likely to have the less - aggressive HR + / HER2 - subtype of
breast cancer, compared
with African - American
women, who were more likely to have large tumors, more likely to have the aggressive triple - negative
breast cancer, and 40 to 70 percent more likely to be
diagnosed at stage 4 of all subtypes of
breast cancer.